Feedback

Browsing by I

Use an asterisk (*) for partial word searches (e.g. pemph*)

112 results found.

1.
Ordering Recommendation:  

• If pursuing antibody testing to determine autoimmune diabetes mellitus, perform at least 2 antibody tests. In most cases, use glutamic acid decarboxylase antibody in combination with another antibody test. Other antibody tests include Glutamic Acid Decarboxylase Antibody (2001771), Insulin Antibody (0099228), Islet Cell Cytoplasmic Antibody, IgG (0050138), and Zinc Transporter 8 Antibody (2006196).
• Most useful to establish autoimmune etiology in previously diagnosed type 1 DM. Do not use to differentiate type 1 DM from type 2 DM, for most cases.

2.
Ordering Recommendation:  

Optimize drug therapy and monitor patient adherence.

3.
Ordering Recommendation:  

Detect IDH1 and IDH2 mutations in whole blood or bone marrow. May have prognostic significance in patients with hematologic malignancies, depending on the clinical and genetic context. For FFPE tissues, use IDH1 and IDH2 Mutation Analysis, Exon 4, Formalin-Fixed, Paraffin-Embedded (FFPE) Tissue (2014188).

4.
Ordering Recommendation:  

IDH1/IDH2 mutational status is a prognostic marker in individuals with low- and high-grade gliomas. Aid in distinguishing a primary from a secondary glioblastoma.

5.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

6.
Ordering Recommendation:  

Use to differentiate tumor from reactive gliosis when morphology indicates tumor may be a glioma.

7.
Ordering Recommendation:  

Evaluate patients with recurrent infection for the possibility of IgA deficiency (IgAD). Use prior to transfusion or in possible transfusion reactions to determine the presence of anti-IgA antibodies in patients with selective IgA deficiency.

8.
Ordering Recommendation:  

Aids in diagnosis of growth hormone excess or deficiency disorders.

9.
Ordering Recommendation:  

Most sensitive method to detect IGH-BCL2 fusion in formalin-fixed, paraffin-embedded (FFPE) tissue specimens.

10.
Ordering Recommendation:  

Aid in diagnosis of mantle cell lymphoma if cyclin testing is noninformative.

11.
Ordering Recommendation:  

Facilitates diagnosis of Burkitt lymphoma (BL) and B-cell lymphoma with features intermediate between BL and diffuse large B-cell lymphoma (DLBCL).

12.
Ordering Recommendation:  

Determine risk group in newly diagnosed CLL.

13.
Ordering Recommendation:  

Optimize drug therapy and monitor patient adherence.

14.
Ordering Recommendation:  

Detect circulating immune complexes.

15.
Ordering Recommendation:  

Use in the initial evaluation of individuals with serum monoclonal protein present and negative IgG, IgA, and IgM immunofixation studies.

16.
Ordering Recommendation:  

Qualitative test confirms the presence of a monoclonal protein and classifies its heavy- and light- chain type. Aids in the detection and management of multiple myeloma and related disorders.

17.
Ordering Recommendation:  

Determine whether to use IgA or IgG tTG and DGP assays.

18.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

19.
Ordering Recommendation:  

Aids in diagnosis of immunodeficiencies.

20.
Ordering Recommendation:  

Aids in diagnosis of immunodeficiencies.

21.
Ordering Recommendation:  

Aids in diagnosis of immunodeficiencies.

22.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

23.
Ordering Recommendation:  

Aids in diagnosis of immunoglobulin disorders.

24.
25.
Ordering Recommendation:  

Aids in diagnosis of immunoglobulin disorders, including monoclonal gammopathies and immunodeficiencies.

26.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

27.
Ordering Recommendation:  

Aids in diagnosis of immunodeficiencies.

28.
Ordering Recommendation:  

Aids in diagnosis of immunodeficiencies.

29.
Ordering Recommendation:  

Aids in diagnosis of immunodeficiencies.

30.
Ordering Recommendation:  

Aids in diagnosis of immunodeficiencies.

31.
Ordering Recommendation:  

Do not order for total IgG measurements. Secondary test in suspected immunoglobulin deficiency. Do not order before IgG, IgA, and IgM measurements are performed.

32.
Ordering Recommendation:  

Aids in diagnosis of multiple sclerosis.

33.
Ordering Recommendation:  

Preferred test is Oligoclonal Band Profile (0080440). Index test aids in the workup of suspected multiple sclerosis.

34.
Ordering Recommendation:  

Aids in diagnosis of multiple sclerosis.

35.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

36.
Ordering Recommendation:  

Aids in diagnosis of immunoglobulin disorders, including monoclonal gammopathies and immunodeficiencies.

37.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

38.
Ordering Recommendation:  

Aids in diagnosis of immunodeficiencies.

39.
Ordering Recommendation:  

Initial test in the workup of suspected immunoglobulin disorders. Order in conjunction with serum protein electrophoresis and immunofixation to rule out plasma cell dyscrasia in adults and older children (>15 years) with suspected hypogammaglobulinemia.

40.
Ordering Recommendation:  

Aids in diagnosis of multiple sclerosis.

41.
Ordering Recommendation:  

Identify encapsulated yeast (eg, Cryptococcus) in CSF.

42.
Ordering Recommendation:  

Refer to Additional Technical Information document.

43.
Ordering Recommendation:  

May be a useful tool for distinguishing ulcerative colitis (UC) from Crohn disease (CD) in patients with suspected inflammatory bowel disease.

44.
Ordering Recommendation:  

Evaluate response failure to infliximab therapy. Determine and adjust dosage or identify the need for change to another anti-TNF-α inhibitor.

45.
Ordering Recommendation:  

Evaluate response failure to infliximab therapy. Determine and adjust dosage or identify the need for change to another anti-TNF-α inhibitor.

46.
Ordering Recommendation:  

Do not use to diagnose acute influenza infections. Serological testing for influenza should be used for research and public health investigations only.

47.
Ordering Recommendation:  

Do not use to diagnose acute influenza infections. Serological testing for influenza should be used for research and public health investigations only.

48.
Ordering Recommendation:  

Do not use to diagnose acute influenza infections. Serological testing for influenza should be used for research and public health investigations only.

49.
Ordering Recommendation:  

Do not use to diagnose acute influenza infections. Serological testing for influenza should be used for research and public health investigations only.

50.
Ordering Recommendation:  

Detect and subtype influenza A virus (H1/H3). Determine H1N1 oseltamivir (Tamiflu) drug resistance.

51.
Ordering Recommendation:  

Follow-up test for patients with documented influenza A. Not a first-line test for the detection of suspected influenza in most clinical situations. Detects and subtypes the 2 predominant strains of circulating influenza A (H1N1 and H3N2).

52.
Ordering Recommendation:  

Do not use to diagnose acute influenza infections. Serological testing for influenza should be used for research and public health investigations only.

53.
Ordering Recommendation:  

Do not use to diagnose acute influenza infections. Serological testing for influenza should be used for research and public health investigations only.

54.
Ordering Recommendation:  

Do not use to diagnose acute influenza infections. Serological testing for influenza should be used for research and public health investigations only.

55.
Ordering Recommendation:  

Not recommended for inpatients or immunocompromised individuals. Acceptable test for the detection of influenza in outpatients.

56.
Ordering Recommendation:  

Acceptable test to detect influenza during influenza season.

57.
Ordering Recommendation:  

Not a preferred stand-alone test.

58.
Ordering Recommendation:  

Confirm diagnosis of inherited insulin resistance syndrome in individuals with clinical and/or biochemical evidence. For initial testing or to rule out inherited insulin resistance syndrome, refer to Insulin, Fasting (0070063) or Fasting Glucose, Plasma or Serum (0020024).

59.
Ordering Recommendation:  

Aid in the diagnosis and monitoring of various hormonal reproductive disorders.

60.
Ordering Recommendation:  

Use to differentiate ovarian tumor with normal CA 125 as stromal or mucinous epithelial tumor. May be used for monitoring recurrence of stromal ovarian tumors.

61.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

62.
Ordering Recommendation:  

Initial screen for inhibitor in plasma.

63.
Ordering Recommendation:  

Initial screen for inhibitor in plasma.

64.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

65.
Ordering Recommendation:  

Preferred test for evaluating acute and chronic exposure to organophosphate pesticides.

66.
Ordering Recommendation:  

• Use to determine presence of antibodies to exogenous insulin analogues. Testing not recommended for patients receiving insulin >2 weeks, as insulin antibody formation may occur.
• If pursuing antibody testing to determine autoimmune diabetes mellitus, perform at least 2 antibody tests. In most cases, use glutamic acid decarboxylase antibody in combination with another antibody test. Other antibody tests include Glutamic Acid Decarboxylase Antibody (2001771), IA-2 Antibody (0050202), Islet Cell Cytoplasmic Antibody, IgG (0050138), and Zinc Transporter 8 Antibody (2006196).
• Do not use to differentiate type 1 DM from type 2 DM, for most cases.

67.
68.
69.
70.
71.
72.
Ordering Recommendation:  

Aids in the detection of insulinoma. Do not use to diagnose diabetes mellitus.

73.
Ordering Recommendation:  

Not recommended to diagnose diabetes mellitus.

74.
75.
76.
Ordering Recommendation:  

Aids in the detection of insulinoma. Do not use to diagnose diabetes mellitus.

77.
78.
Ordering Recommendation:  

May be used as an adjunct to IGF-1 in diagnosis of growth disorders.

79.
Ordering Recommendation:  

Research interest only. For suspected growth hormone disorders, IGF-1 (Insulin-Like Growth Factor 1) (0070125) and Growth Hormone (0070080) are recommended.

80.
81.
Ordering Recommendation:  

Not a first-line test in the evaluation of growth disorders. Aids in workup of suspected anterior hypopituitarism.

82.
Ordering Recommendation:  

Aids in management of individuals treated with interferon beta.

83.
84.
85.
Ordering Recommendation:  

Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders.

86.
Ordering Recommendation:  

Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders.

87.
Ordering Recommendation:  

Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders.

88.
Ordering Recommendation:  

Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders.

89.
Ordering Recommendation:  

Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders.

90.
Ordering Recommendation:  

Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders.

91.
Ordering Recommendation:  

Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders.

92.
Ordering Recommendation:  

Predict response to peginterferon (PEG-IFNα)/ribavirin (RBV) therapy for chronic hepatitis C virus genotype 1 (HCV-1) infection.

93.
Ordering Recommendation:  

Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders.

94.
Ordering Recommendation:  

Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders.

95.
Ordering Recommendation:  

Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders.

96.
Ordering Recommendation:  

Primarily for research and to support attempts to understand the pathogenesis of immune, infectious, allergic, or inflammatory disorders.

97.
Ordering Recommendation:  

May be useful for evaluation of interstitial lung disease in the context of connective tissue disease.

98.
99.
Ordering Recommendation:  

Recommended for determination of iodine excess and monitoring iodine overload in patients administered iodine-containing medications. This test reports total iodine from all iodine-containing species present in the specimen but does not determine the chemical form (species) of the iodine present. For the assessment of nutritional status, Iodine, Urine (2007465) is preferred.

100.
Ordering Recommendation:  

Recommended for the assessment of iodine nutritional status. This test reports total iodine from all iodine-containing species present in the specimen but does not determine the chemical form (species) of the iodine present. For determination of iodine excess and monitoring iodine overload in patients administered iodine-containing medications, refer to Iodine, Serum (2007463).

101.
102.
103.
Ordering Recommendation:  

Aid in the diagnosis of iron deficiency, anemia, and iron overload.

104.
Ordering Recommendation:  

Use to detect iron deficiency anemia, hemochromatosis, and hemosiderosis.

105.
Ordering Recommendation:  

Useful in confirming hepatic iron overload, particularly in individuals with hemochromatosis and no common HFE mutations. Initial approach to diagnosis for hemochromatosis should include Iron and Iron Binding Capacity (0020420) (NOTE: test includes serum transferrin saturation) and Ferritin (0070065).

106.
107.
Ordering Recommendation:  

• If pursuing antibody testing to determine autoimmune diabetes mellitus, perform at least 2 antibody tests. In most cases, use glutamic acid decarboxylase antibody in combination with another antibody test. Other antibody tests include Glutamic Acid Decarboxylase Antibody (2001771), IA-2 Antibody (0050202), Insulin Antibody (0099228), and Zinc Transporter 8 Antibody (2006196).
• Most useful to establish autoimmune etiology in previously diagnosed type 1 DM. Do not use to differentiate type 1 DM from type 2 DM, for most cases.

108.
109.
110.
111.
Ordering Recommendation:  

Monitor exposure to isopropanol.

112.
Ordering Recommendation:  

Optimize drug therapy and monitor patient adherence.